Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Series Title
      Series Title
      Clear All
      Series Title
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Content Type
    • Item Type
    • Is Full-Text Available
    • Subject
    • Country Of Publication
    • Publisher
    • Source
    • Target Audience
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
11,541 result(s) for "Smith, Graham"
Sort by:
Bovine tuberculosis model validation against a field study of badger vaccination with selective culling
Bovine tuberculosis (bTB) is a costly disease in Britain and Ireland shared by cattle and badgers ( Meles meles ), and to reduce the infection in cattle to low levels some form of badger management is considered necessary. We compare the results of a badger field trial where test-positive badgers are culled, and test-negative badgers vaccinated (a TVR approach) with the results of the simulation model originally used to predict the effect of the trial in Northern Ireland. Initial model results depended strongly on whether social perturbation occurred in the badger population following culling, and the field study demonstrated no evidence for such behavior. Here we re-run the model with the initial conditions of the TVR study and with no social perturbation and predict a similar outcome in terms of number of badgers caught, number testing positive, and the substantial decline in prevalence. These results validate our model and demonstrate the utility of such predictive modelling for this disease system. This is particularly important as the UK government moves away from widespread badger culling in England toward more vaccination, as this combined approach of vaccination and selective culling based on test results may give a more robust method of disease management than just vaccination on its own.
Simulating the next steps in badger control for bovine tuberculosis in England
Industry-led culling of badgers has occurred in England to reduce the incidence of bovine tuberculosis in cattle for a number of years. Badger vaccination is also possible, and a move away from culling was “highly desirable” in a recent report to the UK government. Here we used an established simulation model to examine badger control option in a post-cull environment in England. These options included no control, various intermittent culling, badger vaccination and use of a vaccine combined with fertility control. The initial simulated cull led to a dramatic reduction in the number of infected badgers present, which increased slowly if there was no further badger management. All three approaches led to a further reduction in the number of infected badgers, with little to choose between the strategies. We do note that of the management strategies only vaccination on its own leads to a recovery of the badger population, but also an increase in the number of badgers that need to be vaccinated. We conclude that vaccination post-cull, appears to be particularly effective, compared to vaccination when the host population is at carrying capacity.
Progress over 30 years should not mean principles have to change: a Society of Sports Therapists’ perspective
Correspondence to Professor Graham N Smith; g.smith@society-of-sports-therapists.org The development of Sports Therapy principles When The Society of Sports Therapists was formed in 1990, the Sport and Exercise Medicine (SEM) landscape, especially in the UK, was significantly different to how it is today, even though the overriding principles of care and protection remain the same. [...]this point, appointments were frequently made on a ’who knows who’ basis. The recognition of SEM as a medical specialty rather than ‘a hobby’ that the clinicians did in their spare time has also increased the quality of care and the presence of full-time medical practitioner specialists working in clubs and governing bodies.
Cybercrime and digital deviance
\"Cybercrime and Digital Deviance is a work that combines insights from sociology, criminology, and computer science to explore cybercrimes such as hacking and romance scams, along with forms of cyberdeviance such as pornography addiction, trolling, and flaming. Other issues are explored including cybercrime investigations, organized cybercrime, the use of algorithms in policing, cybervictimization, and the theories used to explain cybercrime. Graham and Smith make a conceptual distinction between a terrestrial, physical environment and a single digital environment produced through networked computers. Conceptualizing the online space as a distinct environment for social interaction links this text with assumptions made in the fields of urban sociology or rural criminology. Students in sociology and criminology will have a familiar entry point for understanding what may appear to be a technologically complex course of study. The authors organize all forms of cybercrime and cyberdeviance by applying a typology developed by David Wall: cybertrespass, cyberdeception, cyberviolence, and cyberpornography. This typology is simple enough for students just beginning their inquiry into cybercrime. Because it is based on legal categories of trespassing, fraud, violent crimes against persons, and moral transgressions it provides a solid foundation for deeper study. Taken together, Graham and Smith's application of a digital environment and Wall's cybercrime typology makes this an ideal upper level text for students in sociology and criminal justice. It is also an ideal introductory text for students within the emerging disciplines of cybercrime and cybersecurity\"-- Provided by publisher.
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial
In phase 1 trials, the HIV-1 integrase strand transfer inhibitor cabotegravir (GSK1265744) was well tolerated, both alone, and in combination with the non-nucleoside reverse transcriptase inhibitor rilpivirine. We assessed cabotegravir plus rilpivirine, as a two-drug oral antiretroviral regimen, for the maintenance of viral suppression in antiretroviral-naive HIV-1-infected individuals. In the phase 2b Long-Acting antireTroviral Treatment Enabling (LATTE) trial, a multicentre study done in Canada and the USA, antiretroviral-naive HIV-1-infected adults (aged ≥18 years) were randomly allocated in a 1:1:1:1 ratio to oral cabotegravir 10 mg once a day, 30 mg once a day, 60 mg once a day, or oral efavirenz 600 mg once a day with dual nucleoside reverse transcriptase inhibitors (NRTIs) for 24 weeks of induction. Patients who were virologically suppressed by week 24 received a two-drug maintenance regimen consisting of their randomly allocated cabotegravir dose plus oral rilpivirine 25 mg or continued efavirenz plus NRTIs for an additional 72 weeks. Patients and investigators were masked to doses of cabotegravir received for 96 weeks, but not to the assignment of cabotegravir or efavirenz. The primary endpoint was the proportion of patients with fewer than 50 copies per mL of HIV-1 RNA (US Food and Drug Administration snapshot algorithm) at week 48. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, NCT01641809. Of 243 patients randomly allocated and treated, 156 (86%) of 181 patients in the cabotegravir groups (52 [87%] of 60, 51 [85%] of 60, and 53 [87%] of 61 patients in the 10 mg, 30 mg, and 60 mg groups, respectively) and 46 (74%) of 62 in the efavirenz group had fewer than 50 copies per mL of HIV-1 RNA after induction therapy. After patients in the cabotegravir groups were changed over from dual NRTIs to rilpivirine at week 24, 149 (82%; 95% CI 77–88) patients in the cabotegravir groups (48 [80%; 70–90], 48 [80%; 70–90], and 53 [87%; 78–95] patients in the 10 mg, 30 mg, and 60 mg groups, respectively) versus 44 (71%; 60–82) in the efavirenz group were virologically suppressed at week 48, and 137 (76%; 69–82) receiving cabotegravir (41 [68%; 57–80], 45 [75%; 64–86], and 51 [84%; 74–93] patients in the 10 mg, 30 mg, and 60 mg groups, respectively) versus 39 (63%; 51–75) in the efavirenz group were virologically suppressed at week 96. Treatment-related adverse events were reported by 93 (51%) cabotegravir-treated patients (28 [47%], 32 [53%], and 33 [54%] patients in the 10 mg, 30 mg, and 60 mg groups, respectively) and 42 (68%) efavirenz-treated patients. Six (3%) patients in the cabotegravir groups (one [2%], one [2%], and four [7%] patients in the 10 mg, 30 mg, and 60 mg groups, respectively) withdrew because of treatment-emergent adverse events compared with nine (15%) in the efavirenz group. Cabotegravir plus dual NRTI therapy had potent antiviral activity during the induction phase. As a two-drug maintenance therapy, cabotegravir plus rilpivirine provided antiviral activity similar to efavirenz plus dual NRTIs until the end of week 96. Combined efficacy and safety results lend support to our selection of oral cabotegravir 30 mg once a day for further assessment. LATTE precedes studies of the assessment of longacting injectable formulations of both drugs as a two-drug regimen for the treatment of HIV-1 infection. ViiV Healthcare and Janssen Research and Development.
A first estimate of the structure and density of the populations of pet cats and dogs across Great Britain
Policy development, implementation, and effective contingency response rely on a strong evidence base to ensure success and cost-effectiveness. Where this includes preventing the establishment or spread of zoonotic or veterinary diseases infecting companion cats and dogs, descriptions of the structure and density of the populations of these pets are useful. Similarly, such descriptions may help in supporting diverse fields of study such as; evidence-based veterinary practice, veterinary epidemiology, public health and ecology. As well as maps of where pets are, estimates of how many may rarely, or never, be seen by veterinarians and might not be appropriately managed in the event of a disease outbreak are also important. Unfortunately both sources of evidence are absent from the scientific and regulatory literatures. We make this first estimate of the structure and density of pet populations by using the most recent national population estimates of cats and dogs across Great Britain and subdividing these spatially, and categorically across ownership classes. For the spatial model we used the location and size of veterinary practises across GB to predict the local density of pets, using client travel time to define catchments around practises, and combined this with residential address data to estimate the rate of ownership. For the estimates of pets which may provoke problems in managing a veterinary or zoonotic disease we reviewed the literature and defined a comprehensive suite of ownership classes for cats and dogs, collated estimates of the sub-populations for each ownership class as well as their rates of interaction and produced a coherent scaled description of the structure of the national population. The predicted density of pets varied substantially, with the lowest densities in rural areas, and the highest in the centres of large cities where each species could exceed 2500 animals.km-2. Conversely, the number of pets per household showed the opposite relationship. Both qualitative and quantitative validation support key assumptions in the model structure and suggest the model is useful at predicting the populations of cats at geographical scales important for decision-making, although it also indicates where further research may improve model performance. In the event of an animal health crisis, it appears that almost all dogs could be brought under control rapidly. For cats, a substantial and unknown number might never be bought under control and would be less likely to receive veterinary support to facilitate surveillance and disease management; we estimate this to be at least 1.5 million cats. In addition, the lack of spare capacity to care for unowned cats in welfare organisations suggests that any increase in their rate of acquisition of cats, or any decrease in the rate of re-homing might provoke problems during a period of crisis.